Polytherapy with two or more antihypertensive drugs to lower blood pressure in elderly Ontarians. Room for improvement

Department of Medicine, Libin Cardiovascular Institute, University of Calgary, Calgary, AB, Canada.
The Canadian journal of cardiology (Impact Factor: 3.71). 08/2007; 23(10):783-7. DOI: 10.1016/S0828-282X(07)70827-9
Source: PubMed


Although guidelines now recommend polytherapy to achieve blood pressure targets, little is know about which antihypertensive drugs are combined in clinical practice.
To examine current practices for the coprescribing of antihypertensive agents.
A population-based cohort study was performed using linked administrative databases on all Ontario residents 66 years of age or older who were newly treated for hypertension between July 1, 1994, and March 31, 2002, and did not have diabetes or other relevant comorbidities. All patients were followed for two years to determine which antihypertensives were prescribed concurrently.
Of the 166,018 patients in the described cohort, 1819 (1%) were prescribed a combination therapy tablet as their first-line therapy. The number of patients prescribed antihypertensive polytherapy within the first two years of diagnosis increased from 2071 (21%) of the 9825 hypertensive patients starting treatment in the second half of 1994 to 2578 (37%) of the 6988 hypertensive patients beginning treatment in the first quarter of 2002 (P<0.0001). Overall, 11,003 (27%) of polytherapy prescriptions were for drugs without additive hypotensive effects when combined and this proportion did not change over time.
Although there has been an increase in the use of polytherapy in elderly hypertensive patients without comorbidities in Ontario over the past decade, more than one-quarter of the two drugs prescribed together have not been proven to have additive hypotensive effects. Because this likely contributes to suboptimal blood pressure control rates, future guidelines and educational programs should devote increased attention to the choice of optimal polytherapy combinations.

Download full-text


Available from: Karen Tu, Jan 12, 2015
  • Source
    • "Secondary outcome measures include mortality due to CVD and coronary artery disease (CAD), and all-cause mortality; hospitalisations for stroke and CAD; differences in rates of initiation of antihypertensive drug therapy (Tu et al., 2002); differences in rates of hypertension drug treatment (one antihypertensive drug versus polytherapy) (Campbell et al., 2007); and health service utilisation and cost-benefit analysis (Drummond et al., 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: High blood pressure is an important and modifiable cardiovascular disease risk factor that remains under-detected and under-treated. Community-level interventions that address high blood pressure and other modifiable risk factors are a promising strategy to improve cardiovascular health in populations. The present study is a community cluster-randomised trial testing the effectiveness of CHAP (Cardiovascular Health Awareness Program) on the cardiovascular health of older adults. Thirty-nine mid-sized communities in Ontario, Canada were stratified by geographic location and size of the population aged >or=65 years and randomly allocated to receive CHAP or no intervention. In CHAP communities, residents aged >or=65 years were invited to attend cardiovascular risk assessment sessions held in pharmacies over 10 weeks in Fall, 2006. Sessions included blood pressure measurement and feedback to family physicians. Trained volunteers delivered the program with support from pharmacists, community nurses and local organisations. The primary outcome measure is the relative change in the mean annual rate of hospital admission for acute myocardial infarction, congestive heart failure and stroke (composite end-point) among residents aged >or=65 years in intervention and control communities, using routinely collected, population-based administrative health data. This paper highlights considerations in design, implementation and evaluation of a large-scale, community-wide cardiovascular health promotion initiative.
    Preventive Medicine 06/2008; 46(6):537-44. DOI:10.1016/j.ypmed.2008.02.005 · 3.09 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Le présent article résume et met en lumière les principaux messages des recommandations de 2007 du Programme éducatif canadien sur l’hypertension pour la prise en charge et le diagnostic de l’hypertension. C’est la huitième mise à jour annuelle. Les nouveaux messages importants des recommandations de 2007 du Programme éducatif canadien sur l’hypertension exposent le besoin d’évaluer les adultes ayant une tension artérielle (TA) normale-élevée tous les ans et de réduire la quantité de sel à moins de 100 mmol/jour dans le régime des Canadiens. Ces nouvelles recommandations n’ont pas encore été intégrées aux précédents éléments, qui demeurent toujours importants, pour le diagnostic, la prise en charge et le traitement des patients hypertendus, notamment l’évaluation de la TA chez tous les adultes à toutes les consultations pertinentes, le diagnostic rapide de l’hypertension, l’évaluation et la prise en charge du risque cardiovasculaire global, l’insistance sur les modifications au mode de vie comme pierre angulaire du traitement antihypertenseur, le traitement ciblé afin d’obtenir une réduction optimale du risque cardiovasculaire, le recours à une polythérapie d’antihypertenseurs et de modifications au mode de vie pour obtenir les cibles recommandées et l’orientation sur l’observance du traitement. On discute de la possibilité de changements mineurs aux pharmacothérapies et de nouvelles recommandations pour les examens de laboratoire systématiques.
    The Canadian journal of cardiology 05/2007; 23(7):521–527. DOI:10.1016/S0828-282X(07)70796-1 · 3.94 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We have reported that the prevalence of diagnosed hypertension increased by 60% from 1995 to 2005 in Ontario. In the present study, we asked whether this increase is explained by a decrease in the mortality rate. We performed a population-based cohort study using linked administrative data for Ontario, a Canadian province with over 12 million residents. We identified prevalent cases of hypertension using a validated case-definition algorithm for hypertension, and we examined trends in mortality from 1995 to 2005 among adults aged 20 years and older with hypertension. The age- and sex-adjusted mortality among patients with hypertension decreased from 11.3 per 1000 people in 1995 to 9.6 per 1000 in 2005 (p < 0.001), which is a relative reduction of 15.5%. We found that the relative decrease in age-adjusted mortality was higher among men than among women (-22.2% v. -7.3%, p < 0.001). Mortality rates among patients with hypertension have decreased. Along with an increasing incidence, decreased mortality rates may contribute to the increased prevalence of diagnosed hypertension. Sex-related discrepancies in the reduction of mortality warrant further investigation.
    Canadian Medical Association Journal 05/2008; 178(11):1436-40. DOI:10.1503/cmaj.080096 · 5.96 Impact Factor
Show more